We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,469 results
  1. Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage

    Machado-Joseph disease (MJD/SCA3) is the most frequent dominant ataxia worldwide. It is caused by a (CAG) n expansion. MJD has two major ancestral...

    Sandra Martins, Ashraf Yahia, ... Jorge Sequeiros in Human Genetics
    Article Open access 14 November 2023
  2. Machado Joseph-Disease Is Rare in the Peruvian Population

    Spinocerebellar ataxia type 3 or Machado-Joseph disease (MJD/SCA3) is the most prevalent autosomal dominant cerebellar ataxia worldwide, but its...

    Mario Cornejo-Olivas, Lesly Solis-Ponce, ... Elison Sarapura-Castro in The Cerebellum
    Article 03 November 2022
  3. “I Do Not Know How You Feel and How I Feel About That”: Mentalizing Impairments in Machado-Joseph Disease

    Machado Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disease. Mentalizing is...

    Zohar Elyoseph, Dario Geisinger, ... Carlos R. Gordon in The Cerebellum
    Article 28 February 2023
  4. Horizontal Vestibulo-Ocular Reflex Deficit as a Biomarker for Clinical Disease Onset, Severity, and Progression of Machado-Joseph Disease

    Because of the crucial importance of finding a useful biomarker for further clinical trials in Machado-Joseph disease (MJD), and based on our...

    Zohar Elyoseph, Dario Geisinger, ... Carlos R. Gordon in The Cerebellum
    Article 28 March 2023
  5. Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease

    Machado-Joseph disease (MJD) or Spinocerebellar ataxia type 3 (SCA3) is the most common form of dominant SCA worldwide. Magnetic Resonance Imaging...

    Catarina Oliveira Miranda, Rui Jorge Nobre, ... Luís Pereira de Almeida in Acta Neuropathologica Communications
    Article Open access 19 March 2022
  6. Short Communication: Restrictions in care following the COVID-19 pandemic severely impacted Machado-Joseph disease patients: a study in the Azores Islands, Portugal

    This qualitative study describes how the restrictions imposed by the COVID-19 pandemic impacted on Machado-Joseph disease (MJD) patients and their...

    Daniela Couto, Liliana Sousa, ... Álvaro Mendes in Journal of Community Genetics
    Article 18 July 2022
  7. Caffeine Consumption and Interaction with ADORA2A, CYP1A2 and NOS1 Variants Do Not Influence Age at Onset of Machado-Joseph Disease

    Background

    The age at onset (AO) of Machado-Joseph disease (SCA3/MJD), a disorder due to an expanded CAG repeat (CAGexp) in ATXN3 , is quite variable...

    Ana Carolina Martins, Jordânia dos Santos Pinheiro, ... Laura Bannach Jardim in The Cerebellum
    Article 06 July 2024
  8. Diagnostic Delay of Hereditary Ataxias in Brazil: the Case of Machado-Joseph Disease

    Background

    Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a rare disease with diagnosis offered by the Unified Health System in...

    Jordânia dos Santos Pinheiro, Lucas Schenatto Sena, ... Laura Bannach Jardim in The Cerebellum
    Article 14 April 2022
  9. KPNB1 modulates the Machado–Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP

    Machado–Joseph disease (MJD) is characterized by a pathological expansion of the polyglutamine (polyQ) tract within the ataxin-3 protein. Despite its...

    Mahkameh Abeditashi, Jonasz Jeremiasz Weber, ... Thorsten Schmidt in Cellular and Molecular Life Sciences
    Article Open access 06 July 2022
  10. Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease

    Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disease. This disorder...

    Guan-Yu Lin, Chung-Yung Ma, ... Mingli Hsieh in Metabolic Brain Disease
    Article 30 April 2022
  11. Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease

    Machado–Joseph disease (MJD) is the most common dominantly-inherited ataxia worldwide with no effective treatment to prevent, stop or alleviate its...

    Joana Duarte-Neves, Cláudia Cavadas, Luís Pereira de Almeida in Scientific Reports
    Article Open access 08 February 2021
  12. Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease

    Elaine Cristina Miglorini, Victor Henrique Ignácio de Souza, ... Laura Bannach Jardim in The Cerebellum
    Article 29 March 2022
  13. Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado–Joseph Disease

    Although health-related quality of life (HRQoL) has been increasingly valued in healthcare and in clinical trials, there is scarce information about...

    Gabriela Bolzan, Vanessa Bielefeldt Leotti, ... Laura Bannach Jardim in The Cerebellum
    Article 06 July 2021
  14. Genetic Variation in ATXN3 (Ataxin-3) 3′UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3

    Untranslated regions are involved in the regulation of transcriptional and post-transcriptional processes. Characterization of these regions remains...

    Ana Rosa Vieira Melo, Mafalda Raposo, ... Manuela Lima in The Cerebellum
    Article 16 January 2022
  15. Brain structural abnormalities in the preclinical stage of Machado–Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientation dispersion and density imaging

    Objective

    To investigate whether neurite orientation dispersion and density imaging (NODDI) could provide the added value for detecting brain...

    Mengcheng Li, ** Hu in Journal of Neurology
    Article 16 November 2021
  16. Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy

    Machado-Joseph disease (MJD) is relatively prevalent among the Yemenite Jewish subpopulation living in Israel. Currently, there is no treatment able...

    Roy Zaltzman, Zohar Elyoseph, ... Carlos R. Gordon in The Cerebellum
    Article 09 June 2020
  17. Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease

    Purpose

    Machado-Joseph disease (MJD/SCA3) is the most frequent spinocerebellar ataxia worldwide. Pathological studies revealed less melanin-containing...

    Yasuhiro Nakata, Atsuko Sakamoto, Akihiro Kawata in Neuroradiology
    Article 18 June 2020
  18. Mesenchymal stem cell-derived exosomes improve motor function and attenuate neuropathology in a mouse model of Machado-Joseph disease

    Background

    Machado-Joseph disease is the most common autosomal dominant hereditary ataxia worldwide without effective treatment. Mesenchymal stem...

    Hua-**g You, Shu-Bin Fang, ... Zhong Pei in Stem Cell Research & Therapy
    Article Open access 08 June 2020
  19. Trehalose alleviates the phenotype of Machado–Joseph disease mouse models

    Background

    Machado–Joseph disease (MJD), also known as spinocerebellar ataxia type 3, is the most common of the dominantly inherited ataxias worldwide...

    Magda M. Santana, Susana Paixão, ... Luís Pereira de Almeida in Journal of Translational Medicine
    Article Open access 09 April 2020
Did you find what you were looking for? Share feedback.